These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10936576)

  • 1. Factors affecting adverse event reporting during mass ivermectin treatment for onchocerciasis.
    Chijioke CP
    Acta Trop; 2000 Sep; 76(2):169-73. PubMed ID: 10936576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintaining compliance to ivermectin in communities in two West African countries.
    Whitworth JA; Alexander ND; Seed P; Thomas W; Abiose A; Jones BR
    Health Policy Plan; 1996 Sep; 11(3):299-307. PubMed ID: 10160375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions following annual ivermectin treatment of onchocerciasis in Nigeria.
    Oyibo WA; Fagbenro-Beyioku AF
    Int J Infect Dis; 2003 Jun; 7(2):156-9. PubMed ID: 12839719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
    Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
    Opara KN; Fagbemi BO
    J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse events following mass ivermectin therapy for onchocerciasis.
    Chijioke CP; Okonkwo PO
    Trans R Soc Trop Med Hyg; 1992; 86(3):284-6. PubMed ID: 1412654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
    Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M
    Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
    Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
    Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse reactions to the ivermectin treatment of onchocerciasis patients: does infection with the human immunodeficiency virus play a role?
    Kipp W; Bamhuhiiga J; Rubaale T; Kabagambe G
    Ann Trop Med Parasitol; 2005 Jun; 99(4):395-402. PubMed ID: 15949187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The community-based treatment of onchocerciasis in Shao, Kwara State, Nigeria.
    Oyibo WA; Fagenro-Beyioku AF
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):496-503. PubMed ID: 12693582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of onchocerciasis control in the Upper Denkyira East municipal in the forest area of Ghana: Responses of participants and distributors to the CDTI programme.
    Agyemang ANO; Badu K; Baffour-Awuah S; Owusu-Dabo E; Biritwum NK; Garms R; Kruppa TF
    Acta Trop; 2018 Sep; 185():357-362. PubMed ID: 29932933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
    Kipp W; Bamhuhiiga J; Rubaale T; Büttner DW
    Am J Trop Med Hyg; 2003 Dec; 69(6):621-3. PubMed ID: 14740878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious Neurological Adverse Events after Ivermectin-Do They Occur beyond the Indication of Onchocerciasis?
    Chandler RE
    Am J Trop Med Hyg; 2018 Feb; 98(2):382-388. PubMed ID: 29210346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological evaluation of onchocerciasis along Ogun River System, southwest Nigeria.
    Sam-Wobo SO; Adeleke MA; Jayeola OA; Adeyi AO; Oluwole AS; Ikenga M; Lawniye F; Gazama J; Kagni A; Kosoko TO; Agbeyangi O; Bankole S; Toé L; Mafiana CF; Yameogo L
    J Vector Borne Dis; 2012 Jun; 49(2):101-4. PubMed ID: 22898482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onchocerciasis in Imo state, Nigeria (2): the prevalence, intensity and distribution in the upper Imo river basin.
    Dozie I; Onwuliri C; Nwoke B
    Int J Environ Health Res; 2004 Oct; 14(5):359-69. PubMed ID: 15385215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
    Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
    East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Market survey of loiasis: prevalence and adverse reactions to ivermectin using a rapid procedure for loiasis.
    Ibidapo CA; Akinsanya B; Adeoye GO; Otubanjo AO; Okeke P; Okwuzu J; Adejai EO; Braide E
    West Indian Med J; 2008 Mar; 57(2):152-6. PubMed ID: 19565959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment.
    Pacqué M; Muñoz B; Greene BM; Taylor HR
    J Infect Dis; 1991 Feb; 163(2):381-5. PubMed ID: 1988522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.